1. A Multivariable Analysis to Evaluate the Presence or Absence of Gender Differences in Baseline ImPACT Composite Scores and Symptom Severity Ratings in Student-Athletes Ages 12–18 Years.
- Author
-
Hannah, Theodore C., Jumreornvong, Oranicha, Marayati, Naoum F., Spiera, Zachary, Ali, Muhammad, Li, Adam Y., Durbin, John R., Dreher, Nick, Gometz, Alex, Lovell, Mark, and Choudhri, Tanvir
- Subjects
STATISTICS ,CONFIDENCE intervals ,ANALYSIS of variance ,FUNCTIONAL status ,MULTIVARIATE analysis ,ATHLETES ,COGNITION ,SEX distribution ,NEUROPSYCHOLOGICAL tests ,T-test (Statistics) ,STUDENTS ,BRAIN concussion ,DESCRIPTIVE statistics ,CHI-squared test ,DATA analysis software ,DATA analysis - Abstract
Introduction: Gender differences in neurocognitive function have been reported over the past few decades. However, multiple studies that report gender differences in Immediate Post-Concussion Assessment and Cognitive Tests composite scores ignore potential confounders which may lead to inaccurate results. Methods: A total of 4829 male and 2477 female baseline Immediate Post-Concussion Assessment and Cognitive Tests from 2009 to 2019 of subjects ages 12–18 years were used to evaluate gender differences in baseline neurocognitive scores and symptom severity ratings. Regression analyses were used to assess the effects of gender on neurocognitive performance at baseline while controlling for a number of potential confounders including symptom burden at the time of testing. Results: Differences in 3 of 5 composite scores as well as severity rating scores were maintained in multivariate analysis. Females had increased Post-Concussion Symptom Scale (β = 3.54, 95% confidence interval, 2.91 to 4.16, P <.0001) along with higher verbal memory (β = 1.82, 95% confidence interval, 1.15 to 2.50, P <.0001) and visual motor (β = 1.29, 95% confidence interval, 0.85–1.72, P <.0001) scores. Conclusions: Statistically significant gender differences were found in baseline neurocognitive function. This study clarifies for the first time that gender differences in these neurocognitive domains are not simply an artifact of differences in symptom burden. However, the small effect sizes call into question the clinical relevance of these differences. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF